BlackRock, Inc. - Sep 30, 2025 SCHEDULE 13G/A Report for Stoke Therapeutics, Inc. Common Stock (STOK)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: Stoke Therapeutics, Inc. Common Stock
Symbol: STOK
Shares outstanding: 54.9M shares
Disclosed Ownership: 3.73M shares
Ownership: 6.8%
Form type: SCHEDULE 13G/A
Date filed: 10/17/2025, 06:24 PM
Date of event: Sep 30, 2025
Previous filing: Apr 16, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	6.8%	3.73M	3.67M	0	Spencer Fleming	Managing Director